Shawn McCormick - Inspire Medical Independent Director
| INSP Stock | USD 192.76 1.24 0.64% |
Director
Mr. Shawn T. McCormick serves as Independent Director of the Company since January 2017. Mr. McCormick served as Chief Financial Officer of Tornier N.V., a global orthopedic company, from September 2012 until October 2015 when Tornier merged with Wright Medical Group, Inc. Before Tornier, Mr. McCormick served as Chief Operating Officer of Lutonix, Inc., a medical device company, from April 2011 to February 2012, and as Chief Financial Officer and Senior Vice President of ev3 Inc., a global endovascular company, from January 2009 to July 2010, when ev3 was acquired by Covidien plc. From 2002 to 2009, Mr. McCormick held various positions at Medtronic, including as its Vice President, Corporationrationrate Development, where he was responsible for leading Medtronics worldwide business development activities. In addition to serving on our Board of Directors, Mr. McCormick has served on the board of directors of Nevro Corporationration since September 2014 and Surmodics, Inc. since December 2015. Mr. McCormick also served on the board of directors of Entellus Medical, Inc. from November 2014 to February 2018 since 2017.
| Age | 56 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Address | 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416 |
| Phone | 844 672 4357 |
| Web | https://www.inspiresleep.com |
Latest Insider Transactions
McCormick holds a B.S. in Accounting from Arizona State University and an M.B.A. from the University of Minnesota’s Carlson School of Management and is a certified public accountant . We believe Mr. McCormick’s financial expertise and extensive experience in the medical device industry enable him to make valuable contributions to our Board.Shawn McCormick Latest Insider Activity
Tracking and analyzing the buying and selling activities of Shawn McCormick against Inspire Medical stock is an integral part of due diligence when investing in Inspire Medical. Shawn McCormick insider activity provides valuable insight into whether Inspire Medical is net buyers or sellers over its current business cycle. Note, Inspire Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Inspire Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Shawn McCormick over three months ago Disposition of 7518 shares by Shawn McCormick of Inspire Medical at 0.94 subject to Rule 16b-3 | ||
Shawn McCormick over six months ago Acquisition by Shawn McCormick of 716 shares of Inspire Medical subject to Rule 16b-3 |
Inspire Medical Management Efficiency
The company has return on total asset (ROA) of 0.0118 % which means that it generated a profit of $0.0118 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0533 %, meaning that it created $0.0533 on every $100 dollars invested by stockholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 12/01/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 12/01/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Bridget ORourke | Penumbra | 52 | |
| Janet Leeds | Penumbra | 58 | |
| David Hoffmeister | Glaukos Corp | 66 | |
| Gilbert Kliman | Glaukos Corp | 61 | |
| Harpreet Grewal | Penumbra | 53 | |
| Marc Stapley | Glaukos Corp | 50 | |
| Aimee Weisner | Glaukos Corp | 51 | |
| Steve Zarrilli | Globus Medical | 57 | |
| David Davidar | Globus Medical | 54 | |
| James Tobin | Globus Medical | 75 | |
| Daniel Lemaitre | Globus Medical | 66 | |
| Surbhi Sarna | Penumbra | 34 | |
| Ann Rhoads | Globus Medical | 55 | |
| Holly Sit | Penumbra | N/A | |
| Don Kassing | Penumbra | 78 | |
| Thomas Wilder | Penumbra | 56 | |
| Mark Foley | Glaukos Corp | 55 | |
| Arani Bose | Penumbra | 58 | |
Management Performance
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 |
Inspire Medical Systems Leadership Team
Elected by the shareholders, the Inspire Medical's board of directors comprises two types of representatives: Inspire Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inspire. The board's role is to monitor Inspire Medical's management team and ensure that shareholders' interests are well served. Inspire Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inspire Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Georgia GarinoisMelenikiotou, Independent Director | ||
| Megan CPA, Director Reporting | ||
| Timothy Herbert, President, Chief Executive Officer, Director | ||
| Steven Jandrich, Chief Compliance Officer, Vice President of Human Resources | ||
| Martin Abrams, Vice Experience | ||
| John Rondoni, Chief Officer | ||
| Shawn McCormick, Independent Director | ||
| Ivan Lubogo, Senior Sales | ||
| Marilyn Nelson, Independent Chairman of the Board | ||
| Jerry Griffin, Independent Director | ||
| Bryan Phillips, Senior Vice President Chief Compliance Officer, General Counsel, Company Secretary | ||
| Melissa Mann, Chief Officer | ||
| Philip Ebeling, Chief Operating Officer | ||
| Ezgi Yagci, Vice Relations | ||
| Andreas Henke, Executive Europe | ||
| Casey Tansey, Independent Director | ||
| Richard Buchholz, Chief Financial Officer | ||
| Kathy Sherwood, Senior Access | ||
| Gary Ellis, Independent Director | ||
| Carlton Weatherby, Chief Officer | ||
| Randall Ban, Senior Vice President Global Sales and Marketing | ||
| Dana Mead, Independent Director | ||
| Shelley Broader, Independent Director | ||
| Bryan JD, General VP | ||
| Georgia Melenikiotou, Independent Director | ||
| MD FAAOS, Chief Officer |
Inspire Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inspire Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0533 | ||||
| Return On Asset | 0.0118 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.39 B | ||||
| Shares Outstanding | 29.97 M | ||||
| Shares Owned By Insiders | 1.94 % | ||||
| Shares Owned By Institutions | 98.06 % | ||||
| Number Of Shares Shorted | 2.24 M | ||||
| Price To Earning | 15.29 X |
Pair Trading with Inspire Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inspire Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inspire Medical will appreciate offsetting losses from the drop in the long position's value.Moving against Inspire Stock
| 0.61 | DXCM | DexCom Inc Sell-off Trend | PairCorr |
| 0.59 | LH | Laboratory | PairCorr |
| 0.55 | VREX | Varex Imaging Corp | PairCorr |
| 0.47 | GH | Guardant Health | PairCorr |
| 0.44 | MD | Mednax Inc | PairCorr |
The ability to find closely correlated positions to Inspire Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inspire Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inspire Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inspire Medical Systems to buy it.
The correlation of Inspire Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inspire Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inspire Medical Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inspire Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.